Zinc, albumin, frailty, and drug safety in long-term care residents: A translational perspective

Older residents of long-term care facilities (LTCFs) are increasingly treated with complex pharmacotherapy while living with frailty, malnutrition, inflammation, recurrent infection, and reduced physiological reserve. Medication safety in this population cannot rely only on chronological age, diagnostic labels, renal function, or medication counts. This article proposes a translational framework in which serum zinc and albumin are interpreted with frailty and medication review to identify residents at increased risk of adverse drug reactions, infection-related prescribing, and prescribing cascades. Zinc links nutritional status with immune signaling, antioxidant defense, tissue repair, protein synthesis, and gene-regulatory pathways, whereas albumin links plasma zinc transport, inflammation, and pharmacokinetic vulnerability. Because both markers are routinely measurable, they may support individualized clinical management in LTCFs. The proposed approach is not a dosing algorithm, but a practical strategy for integrating biological vulnerability into safer prescribing, deprescribing, monitoring, and nutritional care.

Authors

Publication Details

Journal
Gene & Protein in Disease
Published
2026-11-18
DOI
https://doi.org/10.36922/gpd026290026
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Zinc, albumin, frailty, and drug safety in long-term care residents: A translational perspective

Norifumi Kudeken
2 links
Gene & Protein in Disease
Pharmaceutical Practices and Patient Outcomes
article

Zinc, albumin, frailty, and drug safety in long-term care residents: A translational perspective

Norifumi Kudeken
article en

Abstract

Older residents of long-term care facilities (LTCFs) are increasingly treated with complex pharmacotherapy while living with frailty, malnutrition, inflammation, recurrent infection, and reduced physiological reserve. Medication safety in this population cannot rely only on chronological age, diagnostic labels, renal function, or medication counts. This article proposes a translational framework in which serum zinc and albumin are interpreted with frailty and medication review to identify residents at increased risk of adverse drug reactions, infection-related prescribing, and prescribing cascades. Zinc links nutritional status with immune signaling, antioxidant defense, tissue repair, protein synthesis, and gene-regulatory pathways, whereas albumin links plasma zinc transport, inflammation, and pharmacokinetic vulnerability. Because both markers are routinely measurable, they may support individualized clinical management in LTCFs. The proposed approach is not a dosing algorithm, but a practical strategy for integrating biological vulnerability into safer prescribing, deprescribing, monitoring, and nutritional care.

Gene & Protein in DiseaseVol. 0(0)
Good health and well-being
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon